Adam Feuerstein comments on Ariad.. Maybe someone should email Adam Don's summary on possible catalysts to help him out. No time for me.. http://www.thestreet.com/_yahoo/story/10987614/1/biotech-stock-mailbag-orexigen-therapeutics.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite=NA